Pharmaceuticals, Biotechnology and Life Sciences
TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today…
CORAL GABLES, Fla., June 28, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company…
NEW YORK and SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company…
Submission supported by previously announced data from Phase 3 MPOWERED™ studyNEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) — Chiasma, Inc.…
SOUTH SAN FRANCISCO, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) today announced that it has…
Company announcement – No. 42/ 2021 ZEALAND PHARMA A/S – SHARE BUY-BACK PROGRAM UNDER SAFE HARBOUR TO AQUIRE DANISH COMMON STOCK…
– Company to focus on development of next-generation phage product candidates from ImmunoPhage platform and monoclonal antibody and nanobody programs…
CAMBRIDGE, Mass., June 28, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on…
BOSTON and JERUSALEM, June 28, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of…
Thousand Oaks, CA, June 28, 2021 (GLOBE NEWSWIRE) — CBDual Biotechnology Corp’s parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer…